Clinical Trial Update: Study of the Efficacy and Safety of AMT-101 in Combination With Adalimumab in Subjects With Ulcerative Colitis (MARKET) [Phase 2]

View source ↗

Summary

Phase 2 trial update on AMT-101 in combination with adalimumab in ulcerative colitis completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)
• AMT-101

Snippet

Sponsor: Applied Molecular Transport | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED